Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Kelly E. et al, (2023), J Infect
A multistage mixed-methods evaluation protocol for the UKHSA testing response during the COVID-19 pandemic in England
Naidoo R. et al, (2022)
Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable.
Haeusler IL. et al, (2022), Clin Exp Immunol, 209, 188 - 200
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA. et al, (2022), Lancet, 399, 521 - 529